Most recent

CLSI M57-Ed1 (R2022)

Principles and Procedures for the Development of Epidemiological Cutoff Values for Antifungal Susceptibility Testing - 1st Edition

This guideline includes the criteria for developing and using epidemiological cutoff values for guiding clinical decisions when testing fungal species and antifungal agent combinations for which there are no breakpoints. This reaffirmed document has been reviewed and confirmed as suitable to remain published without revision to content, as of February 2022. The document’s next scheduled review is generally five years after the reaffirmation date.

CONTENT PROVIDER
Clinical And Laboratory Standards Institute [clsi]

Included in Packages
This standard is not included in any packages.
Document History
We have no document history for this standard.
Amendments & Corrections
We have no amendments or corrections for this standard.